Aizant

Aizant is a drug discovery company in Hyderabad, India, founded in 2005.

bringing your pharma vision to life.

Employees
501–1000
Founded
2005
Business Model
B2B
Website
aizant.com

About

Aizant provides pharmaceutical development, contract manufacturing, and clinical research services for pharmaceutical and biotechnology clients. Its capabilities span formulation development, analytical testing, clinical studies, and commercial-scale production. Integrated research laboratories, clinical trial units, and manufacturing facilities support development through commercialization, while its pharmaceutical portfolio offers out-licensing opportunities.

Summary

It lists 501–1000 employees.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Discovery
Series CTotal funding$446.9MNov 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aizant on Indexed.vc
<a href="https://indexed.vc/companies/aizant"><img src="https://indexed.vc/api/badge/company/aizant" alt="Aizant on Indexed.vc" width="260" height="76" /></a>